Co-administration of APD668, a G protein-coupled receptor 119 agonist and linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in mice fed on a high trans-fat diet
Keywords: آگونیست GPR119; GPR119 agonist; GLP-1; DPPIV inhibitor; Dyslipidemia; NASH; NASH; Non-alcoholic steatohepatitis; NAFLD; Non-alcoholic fatty liver disease; GLP-1; Glucagon-Like Peptide-1; GIP; Gastric Inhibitory Peptide; DPPIV; Dipeptidyl Peptidase IV; MCP-1; Monocyte che